Part III - DRUGS AND DEVICES
- Section 21-216 - Adulterated drugs and devices
- Section 21-217 - Misbranded drugs and devices - In general
- Section 21-218 - Additional grounds of drug misbranding
- Section 21-219 - Exemptions from labeling and packaging requirements for drugs and devices subject to additional processing, labeling, or packing
- Section 21-220 - Prescription requirements
- Section 21-221 - Label requirements for prescription drugs; exemption from provisions on misbranded drugs
- Section 21-222 - Construction of Section 21-220 and 21-221
- Section 21-223 - New drugs - In general
- Section 21-224 - New drugs - Exemption when intended for investigational use only
- Section 21-225 - New drugs - Inspection of records
- Section 21-226 - Printed information for use of practitioners
- Section 21-227 - Provision of information on request of Secretary